医学
接收机工作特性
回顾性队列研究
糖尿病
队列
内科学
肥胖
外科
肥胖手术
代谢综合征
胃分流术
减肥
内分泌学
作者
Khushboo Gala,Wissam Ghusn,Vítor Ottoboni Brunaldi,Eric J. Vargas,Andrew C. Storm,Andrés Acosta,Barham K. Abu Dayyeh
标识
DOI:10.1177/26317745241247175
摘要
Background: Endoscopic sleeve gastroplasty (ESG) is a safe and effective obesity treatment. The individualized metabolic score (IMS) is a validated score that uses preoperative variables predicting T2D remission (DR) in bariatric surgery. Objectives: We evaluated the applicability of using the IMS score to predict DR in patients after ESG. Design/Methods: We performed a retrospective review of patients with obesity and T2D who underwent ESG. We calculated DR, IMS score, and severity, and divided patients based on IMS category. Results: The cohort comprised 20 patients: 25% (5) mild, 55% (11) moderate, and 20% (4) severe IMS stages. DR was achieved in 60%, 45.5%, and 0% of patients with mild, moderate, and severe IMS scores ( p = 0.08), respectively. IMS score was significantly associated with DR ( p = 0.03), with the area under the curve of the receiver operating characteristic for predicting DR 0.85. Conclusion: These pilot data demonstrate that the IMS score appears to be useful in predicting DR after ESG.
科研通智能强力驱动
Strongly Powered by AbleSci AI